Epstein-Barr virus interferes with the amplification of IFNalpha secretion by activating suppressor of cytokine signaling 3 in primary human monocytes. 2010

François Michaud, and François Coulombe, and Eric Gaudreault, and Carine Paquet-Bouchard, and Marek Rola-Pleszczynski, and Jean Gosselin
Innate Immunology Laboratory, CHUQ Research Center (CHUL) and Department of Molecular Medicine, Faculty of Medicine, Université Laval, Quebec, Quebec, Canada.

BACKGROUND Epstein-Barr virus is recognized to cause lymphoproliferative disorders and is also associated with cancer. Evidence suggests that monocytes are likely to be involved in EBV pathogenesis, especially due to a number of cellular functions altered in EBV-infected monocytes, a process that may affect efficient host defense. Because type I interferons (IFNs) are crucial mediators of host defense against viruses, we investigated the effect of EBV infection on the IFNalpha pathway in primary human monocytes. RESULTS Infection of monocytes with EBV induced IFNalpha secretion but inhibited the positive feedback loop for the amplification of IFNalpha. We showed that EBV infection induced the expression of suppressor of cytokine signaling 3 (SOCS3) and, to a lesser extent, SOCS1, two proteins known to interfere with the amplification of IFNalpha secretion mediated by the JAK/STAT signal transduction pathway. EBV infection correlated with a blockage in the activation of JAK/STAT pathway members and affected the level of phosphorylated IFN regulatory factor 7 (IRF7). Depletion of SOCS3, but not SOCS1, by small interfering RNA (siRNA) abrogated the inhibitory effect of EBV on JAK/STAT pathway activation and significantly restored IFNalpha secretion. Finally, transfection of monocytes with the viral protein Zta caused the upregulation of SOCS3, an event that could not be recapitulated with mutated Zta. CONCLUSIONS We propose that EBV protein Zta activates SOCS3 protein as an immune escape mechanism that both suppresses optimal IFNalpha secretion by human monocytes and favors a state of type I IFN irresponsiveness in these cells. This immunomodulatory effect is important to better understand the aspects of the immune response to EBV.

UI MeSH Term Description Entries
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071222 Suppressor of Cytokine Signaling 1 Protein A suppressor of cytokine signaling protein that consists of an N-terminal kinase-inhibitory region, a central SH2 DOMAIN, a characteristic C-terminal SOCS box (a 40-amino acid motif, which functions to recruit E3 UBIQUITIN-PROTEIN LIGASE COMPLEXES). SOCS1 functions as a negative regulator of CYTOKINES that signal through the JANUS KINASES-STAT 3 TRANSCRIPTION FACTOR (JAK/STAT3) pathway by inhibiting the activity of JANUS KINASES. SOCS1 Protein,Suppressor of Cytokine Signaling Protein 1 -,Protein, SOCS1,Suppressor of Cytokine Signaling Protein 1
D000071223 Suppressor of Cytokine Signaling 3 Protein A suppressor of cytokine signaling protein that consists of an N-terminal kinase-inhibitory region, a central SH2 DOMAIN, a characteristic C-terminal SOCS box (a 40-amino acid motif, which functions to recruit E3 UBIQUITIN-PROTEIN LIGASE COMPLEXES). SOCS3 inhibits cytokine signaling by binding to RECEPTOR PROTEIN-TYROSINE KINASES as well as CYTOKINE RECEPTOR GP130; ERYTHROPOIETIN RECEPTORS; INSULIN RECEPTOR; and the LEPTIN RECEPTOR. Its functions include suppression of ERYTHROPOIESIS in the fetal liver. SOCS3 Protein,Suppressor of Cytokine Signaling Protein 3,Protein, SOCS3
D014764 Viral Proteins Proteins found in any species of virus. Gene Products, Viral,Viral Gene Products,Viral Gene Proteins,Viral Protein,Protein, Viral,Proteins, Viral
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings

Related Publications

François Michaud, and François Coulombe, and Eric Gaudreault, and Carine Paquet-Bouchard, and Marek Rola-Pleszczynski, and Jean Gosselin
March 2000, Journal of virology,
François Michaud, and François Coulombe, and Eric Gaudreault, and Carine Paquet-Bouchard, and Marek Rola-Pleszczynski, and Jean Gosselin
August 2007, Journal of virology,
François Michaud, and François Coulombe, and Eric Gaudreault, and Carine Paquet-Bouchard, and Marek Rola-Pleszczynski, and Jean Gosselin
July 2013, Pediatric blood & cancer,
François Michaud, and François Coulombe, and Eric Gaudreault, and Carine Paquet-Bouchard, and Marek Rola-Pleszczynski, and Jean Gosselin
June 1984, Cancer letters,
François Michaud, and François Coulombe, and Eric Gaudreault, and Carine Paquet-Bouchard, and Marek Rola-Pleszczynski, and Jean Gosselin
January 2001, Cytokine & growth factor reviews,
François Michaud, and François Coulombe, and Eric Gaudreault, and Carine Paquet-Bouchard, and Marek Rola-Pleszczynski, and Jean Gosselin
January 2017, PloS one,
François Michaud, and François Coulombe, and Eric Gaudreault, and Carine Paquet-Bouchard, and Marek Rola-Pleszczynski, and Jean Gosselin
July 2003, Journal of pediatric gastroenterology and nutrition,
François Michaud, and François Coulombe, and Eric Gaudreault, and Carine Paquet-Bouchard, and Marek Rola-Pleszczynski, and Jean Gosselin
May 2012, Peptides,
François Michaud, and François Coulombe, and Eric Gaudreault, and Carine Paquet-Bouchard, and Marek Rola-Pleszczynski, and Jean Gosselin
January 2005, Journal of medical virology,
François Michaud, and François Coulombe, and Eric Gaudreault, and Carine Paquet-Bouchard, and Marek Rola-Pleszczynski, and Jean Gosselin
October 2021, Pathogens (Basel, Switzerland),
Copied contents to your clipboard!